This argues that PD-L1 upregulation by the UPR is different in normal myeloid cells (IRE1α pathway) compared to MDS tumor cells (PERK pathway), an intriguing conundrum since MDS cells are tumor cells of myeloid origin. Here, EIF2AK3 is linked to neoplasm.